1. Klag M, Whelton P, Randall B. Blood pressure and end-stage renal disease in men. New Engl J Med. 1996;334:13–8.
2. Young JH. Blood Pressure and Decline in Kidney Function: Findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol. 2002;13:2776–82.
3. Schaeffner ES, Kurth T, Bowman TS, Gelber RP, Gaziano JM. Blood pressure measures and risk of chronic kidney disease in men. Nephrol Dial Transplant. 2008;23:1246–51.
4. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.
5. Anderson AH, Yang W, Townsend RR, Pan Q, Chertow GM, Kusek JW, et al. Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann Intern Med. NIH Public Access; 2015;162:258–65.
6. Sarafidis PA, Li S, Chen S-C, Collins AJ, Brown WW, Klag MJ, et al. Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease. Am J Med. 2008;121:332–40.
7. Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. NIH Public Access; 2010;55:441–51.
8. Levin A, Steven S, Selina A, Flora A, Sarah G, Braden M. Canadian Chronic Kidney Disease Clinics: A National Survey of Structure, Function and Models of Care. Can J Kidney Heal Dis. 2014;1:29.
9. Cornelissen VA, Smart NA. Exercise Training for Blood Pressure: A Systematic Review and Meta-analysis. J Am Heart Assoc. 2013;2:e004473.
10. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook J V, et al. Lifestyle interventions to reduce raised blood pressure : a systematic review of randomized controlled trials. J Hypertens. 2006;24:215–33.
11. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136:493–503.
12. Howden EJ, Coombes JS, Strand H, Douglas B, Campbell KL, Isbel NM. Exercise training in CKD: Efficacy, adherence, and safety. Am J Kidney Dis. Elsevier Inc; 2015;65:583–91.
13. Heiwe S, Jacobson SH. Exercise training in adults with CKD: A systematic review and meta-analysis. Am J Kidney Dis. Elsevier Inc; 2014;64:383–93.
14. Plantinga LC, Miller ER, Stevens LA, Saran R, Messer K, Flowers N, et al. Blood Pressure Control Among Persons Without and With Chronic Kidney Disease: US Trends and Risk Factors 1999-2006. Hypertension. 2009;54:47–56.
15. Unni S, White K, Goodman M, Ye X, Mavros P, Bash LD, et al. Hypertension Control and Antihypertensive Therapy in Patients With Chronic Kidney Disease. Am J Hypertens. Oxford University Press; 2015;28:814–22.
16. Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009;4:1901–6.
17. Covic A, Apetrii M, Goldsmith D, Kanbay M. SPRINT: The Study Nephrologists Might Take With a Grain of Salt. J Clin Hypertens. 2016;18:1185–8.
18. SPRINT Research Group, Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373:2103–16.
19. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al. Guidelines for the management of chronic kidney disease. Can Med Assoc J. 2008;179:1154–62.
20. Pescatello LS, Arena R, Riebe D, Thompson PD. ACSM’s Guidelines for Exercise Testing and Prescription. In: Wolters Kluwer/Lippincott Williams & Wilkins, editor. 9th ed. Philadelphia; 2014.
21. Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise Standards for Testing and Training. Circulation. 2013;128.
22. Tremblay MS, Warburton DER, Janssen I, Paterson DH, Latimer AE, Rhodes RE, et al. New Canadian Physical Activity Guidelines. Appl Physiol Nutr Metab. 2011;36:36–46.
23. Guidry MA, Blanchard BE, Thompson PD, Maresh CM, Seip RL, Taylor AL, et al. The influence of short and long duration on the blood pressure response to an acute bout of dynamic exercise. Am Heart J. 2006;151:1322.e5-1322.e12.
24. Jones H, Taylor CE, Lewis NCS, George K, Atkinson G. Post‐Exercise Blood Pressure Reduction Is Greater Following Intermittent Than Continuous Exercise and Is Influenced Less by Diurnal Variation. Chronobiol Int. 2009;26:293–306.
25. Bhammar DM, Angadi SS, Gaesser GA. Effects of Fractionized and Continuous Exercise on 24-h Ambulatory Blood Pressure. Med Sci Sport Exerc. 2012;44:2270–6.
26. Inder JD, Carlson DJ, Dieberg G, Hess NC, Smart NA. Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit. Hypertens Res. Nature Publishing Group; 2016;39:88–94.
27. Millar PJ, Bray SR, McGowan CL, MacDonald MJ, McCartney N. Effects of isometric handgrip training among people medicated for hypertension: a multilevel analysis. Blood Press Monit. 2007;12:307–14.
28. Lewis ZH, Lyons EJ, Jarvis JM, Baillargeon J. Using an electronic activity monitor system as an intervention modality: A systematic review. BMC Public Health. BioMed Central; 2015;15:585.
29. Bandura A. Health Promotion by Social Cognitive Means. Heal Educ Behav. 2004;31:143–64.
30. Ashford S, Edmunds J, French DP. What is the best way to change self-efficacy to promote lifestyle and recreational physical activity? A systematic review with meta-analysis. Br J Health Psychol. 2010;15:265–88.
31. Resnick B, Palmer MH, Jenkins LS, Spellbring AM. Path analysis of efficacy expectations and exercise behaviour in older adults. J Adv Nurs. Blackwell Science Ltd; 2000;31:1309–15.
32. Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:830–7.
33. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, et al. Prognostic Role of Ambulatory Blood Pressure Measurement in Patients With Nondialysis Chronic Kidney Disease. Arch Intern Med. American Medical Association; 2011;171:2873–8.
34. O’Brien E, Mee F, Atkins N, O’Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens. 1991;9:573–4.
35. Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada’s 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017;33:557–76.
36. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.
37. World Health Organization Collaborating Centre for Drug Statistics Methodology - Definition and general considerations [Internet]. [cited 2017 Aug 8]. Available from: https://www.whocc.no/atc_ddd_index/
38. Hsu KL, Fink JC, Ginsberg JS, Yoffe M, Zhan M, Fink W, et al. Self-reported Medication Adherence and Adverse Patient Safety Events in CKD. Am J Kidney Dis. NIH Public Access; 2015;66:621–9.
39. Crapo RO, Casaburi R, Coates AL, Enright PL, MacIntyre NR, McKay RT, et al. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–7.
40. Migueles JH, Cadenas-Sanchez C, Ekelund U, Delisle Nyström C, Mora-Gonzalez J, Löf M, et al. Accelerometer Data Collection and Processing Criteria to Assess Physical Activity and Other Outcomes: A Systematic Review and Practical Considerations. Sport Med. 2017;47:1821–45.
41. International Physical Activity Questionnaire [Internet]. [cited 2017 Jun 29]. Available from: www.ipaq.ki.se
42. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. BioMed Central; 2011;8:115.
43. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994/10/01. 1994;3:329–38.
44. Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Gheorghe A, Keeley T, et al. Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review. Eller K, editor. PLoS One. 2017;12:e0179733.
45. EuroQol Group. EQ-5D: A standardised instrument for use as a measure of health outcome. [Internet]. [cited 2017 Aug 24]. Available from: https://euroqol.org/
46. Cooper CL, Hind D, Duncan R, Walters S, Lartey A, Lee E, et al. A rapid review indicated higher recruitment rates in treatment trials than in prevention trials. J Clin Epidemiol. 2015;68:347–54.
47. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
48. Inker LA, Eckfeldt J, Levey AS, Leiendecker-Foster C, Rynders G, Manzi J, et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. NIH Public Access; 2011;58:682–4.
49. Vollmer WM, Appel LJ, Svetkey LP, Moore TJ, Vogt TM, Conlin PR, et al. Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens. 2005;19:77–82.
50. Dimeo F, Pagonas N, Seibert F, Arndt R, Zidek W, Westhoff TH. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension. 2012;60:653–8.
51. Guimaraes GV, de Barros Cruz LG, Fernandes-Silva MM, Dorea EL, Bocchi EA. Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: A randomized controlled trial (HEx trial). Int J Cardiol. 2014;172:434–41.
52. The Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure-lowering treatment based on cardiovascular risk : a meta-analysis of individual patient data. Lancet. Elsevier Ltd; 2014;384:591–8.
53. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003/04/30. 2003;41:582–92.
54. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of Comprehensive Lifestyle Modification on Blood Pressure Control. JAMA. 2003;289:2083–93.
55. Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:1175–80.
56. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45:994–1001.
57. Collister D, Russell R, Verdon J, Beaulieu M, Levin A. Perspectives on optimizing care of patients in multidisciplinary chronic kidney disease clinics. Can J Kidney Heal Dis. Canadian Journal of Kidney Health and Disease; 2016;3:32.
58. Hemmelgarn BR, Pannu N, Ahmed SB, Elliott MJ, Tam-Tham H, Lillie E, et al. Determining the research priorities for patients with chronic kidney disease not on dialysis. Nephrol Dial Transplant. Oxford University Press; 2016;32:847–54.
59. Rossi AP, Burris DD, Lucas FL, Crocker GA, Wasserman JC. Effects of a renal rehabilitation exercise program in patients with CKD: A randomized, controlled trial. Clin J Am Soc Nephrol. 2014;9:2052–8.
60. Headley S, Germain M, Wood R, Joubert J, Milch C, Evans E, et al. Short-term aerobic exercise and vascular function in CKD stage 3: A randomized controlled trial. Am J Kidney Dis. Elsevier Inc; 2014;64:222–9.
61. Hemmelgarn BR, Pannu N, Ahmed SB, Elliott MJ, Tam-Tham H, Lillie E, et al. Determining the research priorities for patients with chronic kidney disease not on dialysis. Nephrol Dial Transplant. 2017;32:847–54.
62. Robinson-Cohen C, Littman AJ, Duncan GE, Weiss NS, Sachs MC, Ruzinski J, et al. Physical activity and change in estimated GFR among persons with CKD. J Am Soc Nephrol. 2014;25:399–406.